✦ LIBER ✦

Taxol in advanced, hormone-refractory carcinoma of the prostate. A phase II trial of the eastern cooperative oncology group

✍ Scribed by Bruce J. Roth; Patrick J. Loehrer; Beow Yong Yeap; George Wilding; Basil Kasimis; David McLeod

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 440 KB
Volume: 72
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19931015)72:8<2457::aid-cncr2820720825>3.0.co;2-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An eastern cooperative oncology group ph

An eastern cooperative oncology group phase II trial of trimetrexate in the treatment of advanced urothelial carcinoma

✍ Robert S. Witte; Paul Elson; Janardan Khandakar; Donald L. Trump 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 359 KB 👁 1 views

## Background. Trimetrexate is an antifol that differs from methotrexate in ways that may be clinically important. Because methotrexate has activity in advanced bladder cancer, this trial was initiated.

A phase II randomized trial of megestrol

A phase II randomized trial of megestrol acetate or dexamethasone in the treatment of hormonally refractory advanced carcinoma of the prostate

✍ S. R. Patel; L. K. Kvols; R. G. Hahn; H. Windschitl; R. Levitt; T. Therneau 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 329 KB 👁 2 views

A phase II trial of estramustine and eto

A phase II trial of estramustine and etoposide in hormone refractory prostate cancer: A Southwest Oncology Group trial (SWOG 9407)

✍ Kenneth J. Pienta; Emily I. Fisher; Mario A. Eisenberger; Glenn M. Mills; J. Wen 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 1 views

BACKGROUND. The combination of oral estramustine and oral etoposide has generated response rates of 40±50% in patients with hormone refractory prostate cancer in single institution trials. This study tested this regimen in a multi-institutional setting. METHODS. Fifty-®ve patients were accrued over

Phase II trial of trimetrexate for patie

Phase II trial of trimetrexate for patients with advanced gastric carcinoma : An Eastern Cooperative Oncology Group Study (E1287)

✍ Ramesh K. Ramanathan; Stuart Lipsitz; Robert F. Asbury; Raman Qazi; Bernard R. G 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 1 views

## BACKGROUND. A Phase II study was conducted to evaluate the response, duration of response, and duration of survival of patients with measurable gastric carcinoma treated with trimetrexate (TMTX) who had not had prior chemotherapy. ## METHODS. Thirty-three patients with unresectable or metast

The role of radiotherapy in the manageme

The role of radiotherapy in the management of operable locally advanced breast carcinoma : Results of a randomized trial by the Eastern Cooperative Oncology Group

✍ John E. Olson; Donna Neuberg; Kishan J. Pandya; Melvyn P. Richter; Lawrence J. S 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 1 views

## BACKGROUND. The purpose of this study was to test the role of radiotherapy follow-

Vinblastine, ifosfamide, and gallium nit

Vinblastine, ifosfamide, and gallium nitrate—an active new regimen in patients with advanced carcinoma of the urothelium : A Phase II trial of the Eastern Cooperative Oncology Group (E5892)

✍ Robert Dreicer; Kathleen J. Propert; Bruce J. Roth; Lawrence H. Einhorn; Patrick 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 1 views

vinblastine, ifosfamide, and gallium nitrate (VIG) as first-line chemotherapy in patients with locally advanced or metastatic carcinoma of the